211 related articles for article (PubMed ID: 37699115)
1. Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.
Mukhopadhyay ND; Khorasanchi A; Pandey S; Nemani S; Parker G; Deng X; Arthur DW; Urdaneta A; Del Fabbro E
Oncologist; 2024 Feb; 29(2):e206-e212. PubMed ID: 37699115
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation.
Misra S; Lee G; Korzets Y; Wang L; Lau A; Koch CA; Croke J; Helou J
Breast Cancer Res Treat; 2020 Sep; 183(2):391-401. PubMed ID: 32651754
[TBL] [Abstract][Full Text] [Related]
5. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial.
Del Fabbro E; Dev R; Hui D; Palmer L; Bruera E
J Clin Oncol; 2013 Apr; 31(10):1271-6. PubMed ID: 23439759
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.
Page BR; Shaw EG; Lu L; Bryant D; Grisell D; Lesser GJ; Monitto DC; Naughton MJ; Rapp SR; Savona SR; Shah S; Case D; Chan MD
Neuro Oncol; 2015 Oct; 17(10):1393-401. PubMed ID: 25972454
[TBL] [Abstract][Full Text] [Related]
8. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer.
Yennurajalingam S; Frisbee-Hume S; Palmer JL; Delgado-Guay MO; Bull J; Phan AT; Tannir NM; Litton JK; Reddy A; Hui D; Dalal S; Massie L; Reddy SK; Bruera E
J Clin Oncol; 2013 Sep; 31(25):3076-82. PubMed ID: 23897970
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer.
Lesser GJ; Case D; Stark N; Williford S; Giguere J; Garino LA; Naughton MJ; Vitolins MZ; Lively MO; Shaw EG;
J Support Oncol; 2013 Mar; 11(1):31-42. PubMed ID: 22682875
[TBL] [Abstract][Full Text] [Related]
10. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
[TBL] [Abstract][Full Text] [Related]
11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.
Lee EQ; Muzikansky A; Drappatz J; Kesari S; Wong ET; Fadul CE; Reardon DA; Norden AD; Nayak L; Rinne ML; Alexander BM; Arvold ND; Doherty L; Stefanik J; LaFrankie D; Ruland SF; Pulverenti J; Smith KH; Gaffey SC; Hammond S; Wen PY
Neuro Oncol; 2016 Jun; 18(6):849-54. PubMed ID: 26902850
[TBL] [Abstract][Full Text] [Related]
13. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
[TBL] [Abstract][Full Text] [Related]
14. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
[TBL] [Abstract][Full Text] [Related]
15. Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial.
Lund Rasmussen C; Klee Olsen M; Thit Johnsen A; Petersen MA; Lindholm H; Andersen L; Villadsen B; Groenvold M; Pedersen L
Cancer; 2015 Oct; 121(20):3727-36. PubMed ID: 26178160
[TBL] [Abstract][Full Text] [Related]
16. A Double-Blind, Randomized, Placebo-Controlled Trial of
Yennurajalingam S; Tannir NM; Williams JL; Lu Z; Hess KR; Frisbee-Hume S; House HL; Lim ZD; Lim KH; Lopez G; Reddy A; Azhar A; Wong A; Patel SM; Kuban DA; Kaseb AO; Cohen L; Bruera E
J Natl Compr Canc Netw; 2017 Sep; 15(9):1111-1120. PubMed ID: 28874596
[No Abstract] [Full Text] [Related]
17. Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Heudel PE; Van Praagh-Doreau I; Duvert B; Cauvin I; Hardy-Bessard AC; Jacquin JP; Stefani L; Vincent L; Dramais D; Guastalla JP; Blanc E; Belleville A; Lavergne E; Pérol D
Support Care Cancer; 2019 May; 27(5):1879-1889. PubMed ID: 30194492
[TBL] [Abstract][Full Text] [Related]
18. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy of Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Phase II Randomized Double-Blind Controlled Trial.
Yennurajalingam S; Valero V; Lu Z; Liu DD; Busaidy NL; Reuben JM; Diaz Fleming C; Williams JL; Hess KR; Basen-Engquist K; Bruera E
J Natl Compr Canc Netw; 2021 Dec; 20(3):235-243. PubMed ID: 34965510
[TBL] [Abstract][Full Text] [Related]
20. L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.
Cruciani RA; Zhang JJ; Manola J; Cella D; Ansari B; Fisch MJ
J Clin Oncol; 2012 Nov; 30(31):3864-9. PubMed ID: 22987089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
